Zum Hauptinhalt springen
Hochschulbibliothek Niederrhein

Suchergebnisse

Katalog

Mehr
85 Treffer

Suchmaske

Suchtipp für den Bereich Mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Art der Quelle

Thema

Sprache

Geographischer Bezug

Inhaltsanbieter

85 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy.
    Lee, HY ; Min, KW ; et al.
    In: Clinical therapeutics, 2024-05-03
    academicJournal
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    How to Deprescribe Potentially Inappropriate Medications During the Hospital-to-Home Transition: Stakeholder Perspectives on Essential Tasks.
    Wang, J ; Shen, JY ; et al.
    In: Clinical therapeutics, Jg. 45 (2023-10-01), Heft 10, S. 947-956
    academicJournal
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension.
    Lee, HY ; Kim, KI ; et al.
    In: Clinical therapeutics, Jg. 43 (2021-10-01), Heft 10, S. 1746-1756
    academicJournal
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    Effects of Dexmedetomidine and ACE Genotype on Cardiovascular Response During the Decannulation Period of General Anesthesia in Patients With Essential Hypertension.
    Ling, Y ; Gao, H ; et al.
    In: Clinical therapeutics, Jg. 42 (2020-10-01), Heft 10, S. 1992-2000
    academicJournal
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.
    Sung, KC ; Oh, YS ; et al.
    In: Clinical therapeutics, Jg. 40 (2018), Heft 1, S. 50-63.e3
    academicJournal
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
    Lee, HY ; Kim, SY ; et al.
    In: Clinical therapeutics, Jg. 39 (2017-12-01), Heft 12, S. 2366-2379
    academicJournal
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial.
    Sohn, IS ; Kim, CJ ; et al.
    In: Clinical therapeutics, Jg. 39 (2017-08-01), Heft 8, S. 1628-1638
    academicJournal
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy.
    Kim, KI ; Shin, MS ; et al.
    In: Clinical therapeutics, Jg. 38 (2016-10-01), Heft 10, S. 2159-2170
    academicJournal
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
    Lee, JH ; Yang, DH ; et al.
    In: Clinical therapeutics, Jg. 38 (2016-06-01), Heft 6, S. 1485-1497
    academicJournal
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension.
    Lee, HY ; Kim, YJ ; et al.
    In: Clinical therapeutics, Jg. 37 (2015-11-01), Heft 11, S. 2581-2596.e3
    academicJournal
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
    Na, SH ; Lee, HY ; et al.
    In: Clinical therapeutics, Jg. 37 (2015-08-01), Heft 8, S. 1726-39
    academicJournal
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    Evaluation of the efficacy and tolerability of fixed-dose combination therapy of azilsartan and amlodipine besylate in Japanese patients with grade I to II essential hypertension.
    Rakugi, H ; Nakata, E ; et al.
    In: Clinical therapeutics, Jg. 36 (2014-05-01), Heft 5, S. 711-21
    academicJournal
    Wie komme ich dran?
  13. Detailansicht für Treffer 13 öffnen
    Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee, H ; Kim, KS ; et al.
    In: Clinical therapeutics, Jg. 35 (2013-09-01), Heft 9, S. 1337-49
    academicJournal
    Wie komme ich dran?
  14. Detailansicht für Treffer 14 öffnen
    Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi, H ; Ogihara, T ; et al.
    In: Clinical therapeutics, Jg. 34 (2012-04-01), Heft 4, S. 838-48
    academicJournal
    Wie komme ich dran?
  15. Detailansicht für Treffer 15 öffnen
    Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study.
    Parati, G ; Giglio, A ; et al.
    In: Clinical therapeutics, Jg. 32 (2010-07-01), Heft 7, S. 1270-84
    academicJournal
    Wie komme ich dran?
  16. Detailansicht für Treffer 16 öffnen
    Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada, K ; Ogihara, T ; et al.
    In: Clinical therapeutics, Jg. 32 (2010-05-01), Heft 5, S. 861-81
    academicJournal
    Wie komme ich dran?
  17. Detailansicht für Treffer 17 öffnen
    Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension.
    Puig, JG ; Schunkert, H ; et al.
    In: Clinical therapeutics, Jg. 31 (2009-12-01), Heft 12, S. 2839-50
    academicJournal
    Wie komme ich dran?
  18. Detailansicht für Treffer 18 öffnen
    Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis.
    Mesquita Mdo, C ; Sol, EB ; et al.
    In: Clinical therapeutics, Jg. 31 (2009-11-01), Heft 11, S. 2559-64
    academicJournal
    Wie komme ich dran?
  19. Detailansicht für Treffer 19 öffnen
    Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino, FW
    In: Clinical therapeutics, Jg. 31 (2009-09-01), Heft 9, S. 1946-56
    academicJournal
    Wie komme ich dran?
  20. Detailansicht für Treffer 20 öffnen
    Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim, SH ; Chung, WY ; et al.
    In: Clinical therapeutics, Jg. 31 (2009-05-01), Heft 5, S. 988-98
    academicJournal
    Wie komme ich dran?
xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -